Phaedra Chrousos's most recent trade in Vanda Pharmaceuticals Inc was a trade of 41,600 Common Stock done . Disclosure was reported to the exchange on June 4, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Vanda Pharma Inc | Phaedra S. Chrousos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2026 | 41,600 | 164,950 (0%) | 0% | 0 | Common Stock | |
| Vanda Pharma Inc | Phaedra S. Chrousos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 59,225 | 123,350 (0%) | 0% | 0 | Common Stock | |
| Vanda Pharma Inc | Phaedra Chrousos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 40,202 | 40,202 | - | - | Stock Option (right to buy) | |
| Vanda Pharma Inc | Phaedra Chrousos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 21,887 | 64,125 (0%) | 0% | 0 | Common Stock | |
| Vanda Pharma Inc | Phaedra Chrousos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 33,960 | 33,960 | - | - | Stock Option (Right to Buy) | |
| Vanda Pharma Inc | Phaedra Chrousos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 17,307 | 42,238 (0%) | 0% | 0 | Common Stock | |
| Vanda Pharma Inc | Phaedra Chrousos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 24,707 | 24,707 | - | - | Stock Option (Right to Buy) | |
| Vanda Pharma Inc | Phaedra Chrousos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 12,006 | 24,931 (0%) | 0% | 0 | Common Stock |